Löffler BM - Search Results

1

Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium.

Pieske B, Beyermann B, Breu V, Löffler BM, Schlotthauer K, Maier LS, Schmidt-Schweda S, Just H, Hasenfuss G. Pieske B, et al. Among authors: loffler bm. Circulation. 1999 Apr 13;99(14):1802-9. doi: 10.1161/01.cir.99.14.1802. Circulation. 1999. PMID: 10199875

2

Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma.

Löffler BM, Breu V, Clozel M. Löffler BM, et al. FEBS Lett. 1993 Oct 25;333(1-2):108-10. doi: 10.1016/0014-5793(93)80384-7. FEBS Lett. 1993. PMID: 8224145 Free article.

3

In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: implications for endothelin physiology.

Clozel M, Breu V, Gray GA, Löffler BM. Clozel M, et al. Among authors: loffler bm. J Cardiovasc Pharmacol. 1993;22 Suppl 8:S377-9. doi: 10.1097/00005344-199322008-00099. J Cardiovasc Pharmacol. 1993. PMID: 7509992

4

In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors.

Breu V, Löffler BM, Clozel M. Breu V, et al. Among authors: loffler bm. FEBS Lett. 1993 Nov 15;334(2):210-4. doi: 10.1016/0014-5793(93)81713-a. FEBS Lett. 1993. PMID: 8224248 Free article.

5

Involvement of endothelin/nitric oxide balance in hepatic ischemia/reperfusion injury.

Scommotau S, Uhlmann D, Löffler BM, Breu V, Spiegel HU. Scommotau S, et al. Among authors: loffler bm. Langenbecks Arch Surg. 1999 Feb;384(1):65-70. doi: 10.1007/s004230050176. Langenbecks Arch Surg. 1999. PMID: 10367633

6

Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use.

Clozel M, Ramuz H, Clozel JP, Breu V, Hess P, Löffler BM, Coassolo P, Roux S. Clozel M, et al. Among authors: loffler bm. J Pharmacol Exp Ther. 1999 Aug;290(2):840-6. J Pharmacol Exp Ther. 1999. PMID: 10411600

7

The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo.

Clozel M, Gray GA, Breu V, Löffler BM, Osterwalder R. Clozel M, et al. Among authors: loffler bm. Biochem Biophys Res Commun. 1992 Jul 31;186(2):867-73. doi: 10.1016/0006-291x(92)90826-7. Biochem Biophys Res Commun. 1992. PMID: 1323294

8

Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.

Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, Cassal JM, Hirth G, Müller M, Neidhart W, et al. Clozel M, et al. Among authors: loffler bm. J Pharmacol Exp Ther. 1994 Jul;270(1):228-35. J Pharmacol Exp Ther. 1994. PMID: 8035319

9

Downregulation of endothelin receptors by autocrine production of endothelin-1.

Clozel M, Löffler BM, Breu V, Hilfiger L, Maire JP, Butscha B. Clozel M, et al. Among authors: loffler bm. Am J Physiol. 1993 Jul;265(1 Pt 1):C188-92. doi: 10.1152/ajpcell.1993.265.1.C188. Am J Physiol. 1993. PMID: 8338128

10

Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist.

Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, et al. Clozel M, et al. Among authors: loffler bm. Nature. 1993 Oct 21;365(6448):759-61. doi: 10.1038/365759a0. Nature. 1993. PMID: 8413655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters